Poseida Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
5/28/2025
Shares
67,300
Value ($000)
646
Weight
0.0%
2020 Q3 - 2024 Q4 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).